HRTX (STOCKS)
Heron Therapeutics, Inc.
$0.336000
-0.004900 (-1.44%)
Prev close: $0.340900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Craig A. Collard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $63.60M
- Employees
- 122
- P/E (TTM)
- -1.79
- P/B (TTM)
- 11.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.03 | $0.01 | -0.0402 | -394.12% |
|
Mar 2026 (Q1)
|
$-0.04 | $-0.02 | -0.0247 | -161.44% |
|
Dec 2025 (Q4)
|
$-0.02 | $-0.02 | +0.0004 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.04 | $-0.02 | -0.0247 | -161.44% |
Financial Statements
| Revenues | $151.18M |
| Benefits Costs and Expenses | $144.89M |
| Cost Of Revenue | $45.24M |
| Costs And Expenses | $116.80M |
| Gross Profit | $105.94M |
| Operating Expenses | $116.80M |
| Research and Development | $12.30M |
| Other Operating Expenses | $104.50M |
| Operating Income/Loss | -$10.86M |
| Income/Loss From Continuing Operations After Tax | -$34.05M |
| Income/Loss From Continuing Operations Before Tax | $6.28M |
| Net Income/Loss | -$34.05M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.05M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.18 |
| Diluted Earnings Per Share | -$0.18 |
| Basic Average Shares | 557,512,000 |
| Diluted Average Shares | 557,512,000 |
| Assets | $252.26M |
| Current Assets | $229.85M |
| Cash | $42.70M |
| Inventory | $90.59M |
| Other Current Assets | $96.56M |
| Noncurrent Assets | $22.42M |
| Fixed Assets | $11.81M |
| Other Non-current Assets | $10.60M |
| Liabilities | $245.35M |
| Current Liabilities | $92.15M |
| Accounts Payable | $11.64M |
| Wages | $6.63M |
| Other Current Liabilities | $73.87M |
| Noncurrent Liabilities | $153.21M |
| Equity | $6.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.91M |
| Liabilities And Equity | $252.26M |
| Net Cash Flow From Operating Activities | -$11.61M |
| Net Cash Flow From Operating Activities, Continuing | -$11.61M |
| Net Cash Flow From Investing Activities | $2.20M |
| Net Cash Flow From Investing Activities, Continuing | $2.20M |
| Net Cash Flow From Financing Activities | $13.61M |
| Net Cash Flow From Financing Activities, Continuing | $13.61M |
| Net Cash Flow | $4.21M |
| Net Cash Flow, Continuing | $4.21M |
| Comprehensive Income/Loss | -$34.05M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.05M |
| Other Comprehensive Income/Loss | -$31.10M |